RE:RE:RE:RE:RE:RE:RE:SBOTD: Zacks SCR Initiates Coverage of SBOTD With Buy RecNo KLH will not become obsolete. I is the factor that enhances the immune system. So far it is still the best known carrier. What I attemped ti imply is, Stellar Bio the company has a pattent on one avenue of supply of the adjuvant (serum) which is derived from the limpet. Their pattents are effective in the USA and a few other countries. But not in every country world wide. So even their methods can be utalized without recourse in countries where pattentry is not in effect. Should someone choose to do so.
Secondly like any other product like the cell phone, or other inventions and discoveries which are in demand. Around the world enterprizes will be working to discover and produce the adjuvant more efficiently in order to capitalize on some of the market. Just like the process New Zealand is working on at present.
Notsure, If your question was directed at me. Palerider can verrify I was in the last Two runups both in 2013 and 2014. I could produce posts on this board I made from both periods.
I do personally have a fair bit of knowledge about the benifits of KLH.
I would never knock the product it'self. Nor would I be derogatory against the company Stellar Bio. All I was suggesting is Stellar does not have the sole rite to produce the product. Only to the process they use to produce it..
I would suggest, proceed with caution as low volume tends to signify a lack of demand at the current price.